Dolby Laboratories Inc
NYSE:DLB

Watchlist Manager
Dolby Laboratories Inc Logo
Dolby Laboratories Inc
NYSE:DLB
Watchlist
Price: 77.29 USD -0.23% Market Closed
Market Cap: 7.4B USD
Have any thoughts about
Dolby Laboratories Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Dolby Laboratories Inc

Current Assets 1.2B
Cash & Short-Term Investments 482m
Receivables 512.9m
Other Current Assets 199.4m
Non-Current Assets 1.9B
Long-Term Investments 89.3m
PP&E 518.2m
Intangibles 967.7m
Other Non-Current Assets 340.4m
Current Liabilities 417.8m
Accounts Payable 17.4m
Accrued Liabilities 203.3m
Other Current Liabilities 197.2m
Non-Current Liabilities 214.9m
Other Non-Current Liabilities 214.9m

Balance Sheet
Dolby Laboratories Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023 Sep-2024
Assets
Cash & Cash Equivalents
532
516
627
918
797
1 072
1 225
620
745
482
Cash Equivalents
532
516
627
918
797
1 072
1 225
620
745
482
Short-Term Investments
139
122
248
178
119
47
39
189
139
0
Total Receivables
112
77
76
335
386
342
415
420
444
513
Accounts Receivables
102
76
74
332
385
342
415
420
444
513
Other Receivables
11
1
2
2
1
0
0
0
0
0
Inventory
14
16
25
26
32
26
11
24
36
34
Other Current Assets
24
29
35
40
47
61
70
58
123
166
Total Current Assets
821
760
1 011
1 497
1 382
1 547
1 761
1 311
1 488
1 194
PP&E Net
403
444
485
514
537
619
602
560
522
518
PP&E Gross
403
444
485
514
537
619
602
560
522
518
Accumulated Depreciation
202
251
305
362
417
476
538
558
577
619
Intangible Assets
128
215
190
184
181
152
123
112
167
435
Goodwill
308
310
311
328
335
337
341
365
408
533
Long-Term Investments
321
394
314
188
180
52
63
103
98
89
Other Long-Term Assets
153
188
222
155
208
210
217
239
297
340
Other Assets
308
310
311
328
335
337
341
365
408
533
Total Assets
2 133
N/A
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
3 110
+4%
Liabilities
Accounts Payable
21
18
14
22
15
13
18
14
21
17
Accrued Liabilities
129
135
158
174
209
175
205
180
215
203
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
60
61
74
89
82
79
93
83
187
197
Total Current Liabilities
210
213
246
285
307
267
316
278
422
418
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Minority Interest
9
9
7
7
6
6
6
5
17
10
Other Liabilities
108
118
144
210
202
212
186
161
185
205
Total Liabilities
326
N/A
340
+4%
397
+17%
502
+26%
514
+3%
485
-6%
508
+5%
443
-13%
625
+41%
633
+1%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
1 801
1 938
2 083
2 314
2 328
2 443
2 608
2 298
2 392
2 496
Additional Paid In Capital
18
42
61
66
0
0
0
0
0
0
Unrealized Security Profit/Loss
0
1
0
3
2
1
0
6
3
0
Other Equity
12
11
7
13
23
11
10
46
34
19
Total Equity
1 807
N/A
1 970
+9%
2 137
+8%
2 364
+11%
2 307
-2%
2 433
+5%
2 598
+7%
2 246
-14%
2 355
+5%
2 477
+5%
Total Liabilities & Equity
2 133
N/A
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
3 110
+4%
Shares Outstanding
Common Shares Outstanding
101
101
102
103
100
100
101
96
96
95

See Also

Discover More